Volume Sizzlers - Obscene Jeans Corp. (OTCBB:OBJE), MYOS Corp ... - SBWire (press release)

New York City, NY -- (SBWIRE) -- 08/21/2013 -- StockMarketIntel.com issues a special report on the following stocks: Obscene Jeans Corp. (OTCBB:OBJE), MYOS Corp (OTCMKTS:MYOS), Growlife Inc (OTCBB:PHOT), Generex Biotechnology Corporation (OTCMKTS:GNBT)

Obscene Jeans Corp. (OTCBB:OBJE) gained 6.98%, trading on 224,123 shares, to end the trade at $0.460. The stock changed hands in a range of $0.45 to $0.49 bringing its market capitalization to about $5.90 million. If we look at its trading history of the past 52 weeks, the share price suffered a low of $0.25 and was moved to the maximum level of $3.90.

For How Long OBJE will fight for Profitability? Read This Trend Analysis report

MYOS Corp (OTCMKTS:MYOS) declined -6.25%, to complete the trading session at $0.150, with a total volume of 664,609 shares. The stock, on average, trades on a volume of 178,675 shares. It floated in a range of $0.15 to $0.16 during the last trading session, with a beta value of 16.40. Its market capitalization now moved to about $16.71 million. In the past 52 weeks, the share price has not declined below $0.08 and above $0.35. MYOS Corporation, a development stage company, focuses on the discovery, development, and commercialization of nutritional supplements, functional foods, therapeutic products, and other technologies for maintaining or improving the health and performance of muscle tissue. It develops MYO-T12, a natural-myostatin inhibitor that is used to optimize biological activity.

Has MYOS Found The Bottom and Ready To Move Up? Find Out Here

Growlife Inc (OTCBB:PHOT) recorded a fall of -5.88% and was in a range of $0.03-$0.04 before closing at $0.0320. The stock completed the day with a total volume of 3.01 million shares, versus an average volume of 4.42 million shares. The share price hit its 52-week low of $0.0042 and $0.0012 was the best price. Growlife, Inc., through its subsidiaries, manufactures and markets horticulture and lifestyle products in the United States and internationally. It offers LED lights for indoor growing; wireless monitoring and control equipment to operate grow room functions; and plant growing systems and accessories, including nutrients, media, timers, controls, and automated water accessories.

Has PHOT Found The Bottom And Ready To Gain Momentum? Find Out Here

Generex Biotechnology Corporation (OTCMKTS:GNBT) added 4.56% yesterday, bringing its market capitalization around $18.39 million. The share price, after opening at $0.04, made a high of $0.04 and hovered above $0.03 to end the day at $0.0367. The total number of shares that changed hands during the session was 2.61 million shares, as compared to average trading volume of 3.76 million shares. Generex Biotechnology Corporation, a development stage company, engages in the research, development, and commercialization of drug delivery systems and technologies for metabolic and immunological diseases. The company focuses on its proprietary technology for the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator.

What was the Moving Force behind GNBT on Bullish Run? Read This Research Report

Disclaimer:
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list.

Neither StockMarketIntel.com, nor its employees and affiliates are registered as investment advisors or broker/dealers in any jurisdiction whatsoever. Through use of this website viewing or using you agree to hold StockMarketIntel.com, its operators, owners, employees, and affiliates harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources that we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Readers should always do their own due diligence and consult a financial professional. StockMarketIntel.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockMarketIntel.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled company. Any opinions expressed on this website are statements of judgment as of the date of publication and are subject to change without further notice, and may not necessarily be reprinted in future publications or elsewhere.

Read Full disclaimer at: http://stockmarketintel.com/Disclaimer.htm